Population
Porcine coronary artery model
Comparison
Lysophosphatidylcholine at concentrations of 0… vs Control (absence of LPC)
Design
Preclinical
Authors
Loading...
May impair coronary endothelial function in atherosclerosis; hypothesis-generating for LPC as a therapeutic target in humans.
Lysophosphatidylcholine inhibits endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxation and hyperpolarization in porcine coronary arteries, suggesting a novel regulatory mechanism in atherosclerosis.
Eizawa et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: